These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6140228)

  • 21. Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model".
    Langer G; Pühringer W
    Acta Psychiatr Belg; 1980; 80(5):574-83. PubMed ID: 7234451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human alpha1A1-adrenoceptors.
    Nourian Z; Mulvany MJ; Nielsen KB; Pickering DS; Kristensen T
    Eur J Pharmacol; 2008 Oct; 596(1-3):32-40. PubMed ID: 18775692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 24. Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
    Volz HP; Möller HJ; Gerebtzoff A; Bischoff S
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):76-80. PubMed ID: 12111340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.
    Saletu B; Grünberger J; Flener R; Linzmayer L; Sieroslawski H
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):810-21. PubMed ID: 827426
    [No Abstract]   [Full Text] [Related]  

  • 26. Clozapine does not elevate serum prolactin levels in healthy men.
    Lee HS; Kim CH; Song DH; Choi NK; Yoo KJ
    Biol Psychiatry; 1995 Dec; 38(11):762-4. PubMed ID: 8580231
    [No Abstract]   [Full Text] [Related]  

  • 27. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
    Rosenzweig P; Canal M; Patat A; Bergougnan L; Zieleniuk I; Bianchetti G
    Hum Psychopharmacol; 2002 Jan; 17(1):1-13. PubMed ID: 12404702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 29. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.
    Williams JH; Wellman NA; Geaney DP; Cowen PJ; Feldon J; Rawlins JN
    Biol Psychiatry; 1996 Dec; 40(11):1135-43. PubMed ID: 8931917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study).
    Itil TM; Menon GN; Bozak MM; Itil KZ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):397-409. PubMed ID: 6592676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of the neuroleptic agent zetidoline in the rat and the dog.
    Assandri A; Perazzi A; Fontanella L; Ferrari P; Ripamonti A; Tarzia G; Tuan G; Martinelli E
    Drug Metab Dispos; 1984; 12(5):635-40. PubMed ID: 6149917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects.
    Saletu B; Grünberger J; Amrein R; Skreta M
    J Int Med Res; 1981; 9(6):408-33. PubMed ID: 7033012
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Pharmacokinetics and pharmacodynamics of major and minor tranquillizers in humans.
    Curray SH
    Acta Pharm Suec; 1974 Dec; 11(6):665-6. PubMed ID: 237406
    [No Abstract]   [Full Text] [Related]  

  • 36. Antipsychotic agents and serum prolactin levels.
    JAMA; 1976 Nov; 236(19):2175. PubMed ID: 10453
    [No Abstract]   [Full Text] [Related]  

  • 37. Small animal model for evaluating neuroleptic potency.
    Rosenberg JM; Lau-Cam CA
    J Pharm Sci; 1980 Jan; 69(1):74-7. PubMed ID: 6101619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical findings on the pharmacokinetics and pharmacodynamics of a new Czechoslovak-manufactured neuroleptic, isofloxythepin].
    Kazdová E; Lapka R; Rejholec V
    Cesk Psychiatr; 1986 Apr; 82(2):97-100. PubMed ID: 2873898
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychometric evaluation of neuroleptics: a review.
    King DJ
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():602A-603A. PubMed ID: 1354067
    [No Abstract]   [Full Text] [Related]  

  • 40. Complementary psychometric methods in pharmaco-electroencephalography research.
    Emegbo S; Hindmarch I
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():13. PubMed ID: 12809078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.